参考文献/References:
［1］WANG Biao, LI Shuo, MENG Xin, et al Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells ［J］ Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, 36 (8) : 6433-6443.
［2］ASSANHOU A G, LI Wenyuan, ZHANG Lei, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment ［J］. Biomaterials, 2015, 73 (11): 284-295.
［3］CHEN Yanzuo, ZHANG Wei, HUANG Yukun, et al. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor ［J］. International Journal of Pharmaceutics, 2015, 488 (1/2) : 44-58.
［4］TAUB M E, PODILA L, ELY D, et al. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity ［J］. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2005, 33 (11) : 1679-1687.
［5］ZHANG Yilin, SRIRAMAN S K, KENNY H A, et al. Reversal of chemoresistance in ovarian cancer by Co-Delivery of a P-Glycoprotein inhibitor and paclitaxel in a liposomal platform ［J］. Molecular Cancer Therapeutics, 2016, 15 (10) : 2282-2293.
［6］何丽，杨俊毅，胡丽娜．防己诺林碱调控紫杉醇在MDR1-MDCKⅡ细胞模型中的跨膜转运研究 ［J］．中国中药杂志，2010，35（11）：1478-1481．
［7］WANG Jinfeng, LIU Wenming, TU Qin, et al. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery ［J］. Biomacro-molecules, 2011, 12 (1) : 228-234.
［8］BERNABEU E, GONZALEZ L, LEGASPI M J, et al. Paclitaxel-Loaded TPGS-b-PCL nanoparticles: in vitro cytotoxicity and cellular uptake in MCF-7 and MDA-MB-231 cells versus mPEG-b-PCL nanoparticles and abraxane? ［J］. Journal of Nanoscience and Nanotechnology, 2016, 16 (1) : 160-170.
［9］WANG Feihu, ZHANG Dianrui, ZHANG Qiang, et al. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance ［J］. Biomaterials, 2011, 32 (35) : 9444-9456.
［10］LUO Xue, PENG Jian-ming, SU Lan-di, et al. Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression ［J］. Experimental and Therapeutic Medicine, 2016, 11 (2) : 613-618.
相似文献/References:
[1]张雪梅.紫杉醇联合洛铂化疗方案对晚期初治卵巢癌术后
患者早期临床疗效及毒副反应发生率的分析[J].中国计划生育和妇产科,2018,(2):72.
ZHANG Xue-mei.Early clinical efficacy and side effects of paclitaxel combined with
lobaplatin regimen on postoperative patients with advanced ovarian cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(6):72.